Key facts
- B. Lynne Parshall has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $5,169,375.
- Recent insider filing activity is available below.
Insider Trading & Ownership of B. Lynne Parshall
- Location
- Carlsbad, CA
- Summary
- The estimated net worth of B. Lynne Parshall is at least $5,169,375 dollars as of 17 Apr 2026. B. Lynne Parshall is the Director of IONIS PHARMACEUTICALS INC and owns shares of IONIS PHARMACEUTICALS INC (IONS) stock worth about $3.95M. B. Lynne Parshall is the Director of CYTOKINETICS INC and owns shares of CYTOKINETICS INC (CYTK) stock worth about $1.1M. B. Lynne Parshall is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) stock worth about $119.8K.
- Signature
- By: Patrick R. O?Neil, attorney-in-fact For: B. Lynne Parshall
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow B. Lynne Parshall and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: IONIS PHARMACEUTICALS INC ($3,951,947).
- Past-year value change for that position: -$2,381,620.
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of B. Lynne Parshall
IONS
Forms 3/4/5
IONIS PHARMACEUTICALS INC
- Relationship
- Director
- Holdings value
- $3,951,947
- Past year net change
- -$2,381,620
- Change %
- -38%
- Report period
- 15 Apr 2026
CYTK
Forms 3/4/5
CYTOKINETICS INC
- Relationship
- Director
- Holdings value
- $1,097,678
- Past year net change
- -$629,700
- Change %
- -36%
- Report period
- 02 Mar 2026
FHTX
Forms 3/4/5
Foghorn Therapeutics Inc.
- Relationship
- Director
- Holdings value
- $119,750
- Past year net change
- Change %
- Report period
- 17 Jun 2025
Insider Transactions Reported by B. Lynne Parshall:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.